E-GEOD-15928 - Transcription profiling of human PBMC treated with anti-CD25 mAb

Submitted on 1 May 2009, released on 11 May 2009, last updated on 3 May 2014
Homo sapiens
Samples (12)
Array (1)
Protocols (6)
CD25 monoclonal antibody binding to the alpha-chain of the Interleukin-2 (IL-2) receptor, blocks high affinity IL-2 binding thereby preventing complete T cell activation and being of ample importance in transplantation medicine and potentially the treatment of autoimmune disease. However, CD25 antibodies do not only block T cell activation but also prevent activation induced cell death (AICD) attributing a dual function to IL-2. In this study, the modulation of the genomic expression profile of human peripheral blood mononuclear cells (PBMC) with therapeutic concentrations of humanized anti-CD25 mAb was investigated. PBMC were stimulated with CD3 antibody OKT-3 together with recombinant IL-2 in the absence or presence of anti-CD25 mAb. RNA was extracted and subjected to microarray analysis on U133A microarrays (Affymetrix). The expression profile revealed the up-regulation of 62 genes and down-regulation of 38 genes by anti-CD25 mAb, respectively. Experiment Overall Design: Peripheral blood mononuclear cells (PBMC) were stimulated for 8 or 16 hrs with 100 ng/ml OKT-3 together with 100 U/ml recombinant human interleukin-2 (rhIL-2) in the absence or presence of 30 µg/ml anti-CD25 antibody. RNA from cells under such treatment was isolated with Trizol and subjected to microarray analysis onto human U133A microarray following the Affymetrix protocol.
Experiment types
transcription profiling by array, unknown experiment type
Investigation descriptionE-GEOD-15928.idf.txt
Sample and data relationshipE-GEOD-15928.sdrf.txt
Raw data (1)E-GEOD-15928.raw.1.zip
Processed data (1)E-GEOD-15928.processed.1.zip
Array designA-AFFY-33.adf.txt
R ExpressionSetE-GEOD-15928.eSet.r